Literature DB >> 11164892

IL-4 induces serine phosphorylation of the STAT6 transactivation domain in B lymphocytes.

K R Wick1, M T Berton.   

Abstract

The binding of IL-4 to its receptor results in rapid tyrosine phosphorylation of STAT6 by IL-4R-associated Jak kinases. Phosphorylated STAT6 dimerizes and translocates to the nucleus where it acts as a transcription factor to regulate a number of important immune response-related genes in a variety of cell types. Studies of other STAT proteins have demonstrated a role for serine phosphorylation in addition to tyrosine phosphorylation in the regulation of STAT-mediated gene transcription. In this study, phosphoamino acid analysis and two-dimensional phosphopeptide mapping of STAT6 from mouse splenic B cells demonstrated that IL-4 induces phosphorylation of STAT6 on multiple serines. Expression and analysis of a mutant STAT6 protein in which tyrosine 641 (Y641) was replaced with phenylalanine demonstrated that Y641 is necessary for tyrosine phosphorylation of STAT6, but that tyrosine phosphorylation is not necessary for serine phosphorylation. Analysis of STAT6 deletion mutants localized the majority of serine phosphorylation sites to a region between residues 719 and 789, within the previously described transactivation domain. IL-4-stimulated serine phosphorylation of STAT6 was resistant to H7 and HA1004, inhibitors of many serine/threonine kinases including PKC. Serine phosphorylation was also resistant to Wortmannin and LY294002, demonstrating that the IRS/PI 3-kinase pathway is also not required. These data, coupled with previous studies showing that IL-4 does not activate MAPK pathways in lymphocytes, suggest that IL-4 may induce serine phosphorylation of STAT6 by a novel-signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11164892     DOI: 10.1016/s0161-5890(00)00088-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

1.  Histamine affects STAT6 phosphorylation via its effects on IL-4 secretion: role of H1 receptors in the regulation of IL-4 production.

Authors:  Geetanjali Kharmate; Zhongfeng Liu; Eric Patterson; Manzoor M Khan
Journal:  Int Immunopharmacol       Date:  2006-11-20       Impact factor: 4.932

2.  LPS induces the interaction of a transcription factor, LPS-induced TNF-alpha factor, and STAT6(B) with effects on multiple cytokines.

Authors:  Xiaoren Tang; Deborah Levy Marciano; Susan E Leeman; Salomon Amar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-25       Impact factor: 11.205

Review 3.  Regulation of inflammation by interleukin-4: a review of "alternatives".

Authors:  Irina G Luzina; Achsah D Keegan; Nicola M Heller; Graham A W Rook; Terez Shea-Donohue; Sergei P Atamas
Journal:  J Leukoc Biol       Date:  2012-07-10       Impact factor: 4.962

4.  Live cell imaging reveals continuous STAT6 nuclear trafficking.

Authors:  Hui-Chen Chen; Nancy C Reich
Journal:  J Immunol       Date:  2010-05-24       Impact factor: 5.422

5.  Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors.

Authors:  Stéphane Pelletier; François Duhamel; Philippe Coulombe; Michel R Popoff; Sylvain Meloche
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

6.  Shaping the murine macrophage phenotype: IL-4 and cyclic AMP synergistically activate the arginase I promoter.

Authors:  Kathryn E Sheldon; Harish Shandilya; Diane Kepka-Lenhart; Mirjana Poljakovic; Arundhati Ghosh; Sidney M Morris
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422

7.  STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells.

Authors:  Jennifer L Gooch; Barbara Christy; Douglas Yee
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

8.  Interaction of STAT6 with its co-activator SRC-1/NCoA-1 is regulated by dephosphorylation of the latter via PP2A.

Authors:  Tobias Münz; Claudia M Litterst; Edith Pfitzner
Journal:  Nucleic Acids Res       Date:  2010-12-08       Impact factor: 16.971

9.  1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (EC-18) Modulates Th2 Immunity through Attenuation of IL-4 Expression.

Authors:  Sun Young Yoon; Ho Bum Kang; Young-Eun Ko; Su-Hyun Shin; Young-Jun Kim; Ki-Young Sohn; Yong-Hae Han; Saeho Chong; Jae Wha Kim
Journal:  Immune Netw       Date:  2015-04-23       Impact factor: 6.303

Review 10.  Cytokine-Induced Modulation of Colorectal Cancer.

Authors:  Lukas F Mager; Marie-Hélène Wasmer; Tilman T Rau; Philippe Krebs
Journal:  Front Oncol       Date:  2016-04-19       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.